Welcome to the UPF Digital Repository

Hepatitis C virus infection inhibits P-body granule formation in human livers

Show simple item record

dc.contributor.author Pérez Vilaró, Gemma, 1985-
dc.contributor.author Fernández-Carrillo, Carlos
dc.contributor.author Mensa, Laura
dc.contributor.author Miquel, Rosa
dc.contributor.author Sanjuan, Xavier
dc.contributor.author Forns, Xavier
dc.contributor.author Pérez del Pulgar, Sofía
dc.contributor.author Díez Antón, Juana, 1962-
dc.date.accessioned 2017-02-03T08:09:14Z
dc.date.available 2017-02-03T08:09:14Z
dc.date.issued 2015
dc.identifier.citation Pérez Vilaró G, Fernández-Carrillo C, Mensa L, Miquel R, Sanjuan X, Forns X, Pérez del Pulgar S, Díez Antón J. Hepatitis C virus infection inhibits P-body granule formation in human livers. J Hepatol. 2015 Apr; 62(4): 785-90. DOI: 10.1016/j.jhep.2014.11.018
dc.identifier.issn 0168-8278
dc.identifier.uri http://hdl.handle.net/10230/28043
dc.description.abstract BACKGROUND & AIMS: Decoding the myriad of interactions that hepatitis C virus (HCV) establishes with infected cells is mandatory to obtain a complete understanding of HCV biology and its associated pathogenesis. We and others have previously found that HCV infection disrupts the formation of P-bodies in cell culture. These are cytoplasmic RNA granules with key roles in post-transcriptional regulation of gene expression. Therefore, P-body disruption might have consequences beyond viral propagation. However, whether P-body disruption occurs also in vivo is unknown. Aim of this study was to address this important issue. METHODS: Formalin-fixed paraffin-embedded liver biopsies from four groups of patients (healthy donors, patients with non-virus related liver inflammation, HCV- and HBV-infected patients) were immunostained to detect DDX6 and Dcp1, two core P-body components. Changes in the localization of these proteins were assessed by confocal microscopy. RESULTS: HCV specifically inhibited P-body formation in hepatocytes from human livers regardless of viral genotype, inflammation grade or whether the infection was recent or long established. Importantly, this alteration was reversed once HCV was eliminated by therapy. Furthermore, we observed in vivo an unexpected heterogeneity in P-body composition, which might reflect functional specializations. CONCLUSIONS: This is the first comprehensive in vivo P-body analysis that links a pathogenic condition to P-body alterations. Because of their role in gene expression, the alteration of P-bodies should be further studied to understand fully complex HCV-associated pathologies.
dc.description.sponsorship JD and GPV were supported by a grant from the Spanish Ministry of Economy and Competitiveness (BFU2013-44629-R). XF received support in part by a grant from Instituto de Salud Carlos III (PI11/01907), Ministerio de Economía y Competitividad, cofunded by Fondo Europeo de Desarrollo Regional, Unión Europea, Una manera de hacer Europa. XF and SPP also received a grant/nfrom the Roche Organ Transplantation Research Foundation (ROTRF, CI: 442035057). The other authors were supported by grants from the following institutions: CFC from Asociación Española para el Estudio del Hígado, and LM from Instituto de Salud Carlos III, Ministerio de Economía y Competitividad
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartof Journal of Hepatology. 2015 Apr;62(4):785-90
dc.rights © Elsevier http://dx.doi.org/10.1016/j.jhep.2014.11.018
dc.subject.other Virus de l'hepatitis C
dc.subject.other Fetge
dc.title Hepatitis C virus infection inhibits P-body granule formation in human livers
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1016/j.jhep.2014.11.018
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/acceptedVersion


This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account


In collaboration with Compliant to Partaking